EPISODE · Mar 3, 2026 · 1H 5M
Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases
from The Long Run with Luke Timmerman · host Timmerman Report
Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.
What this episode covers
Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.
NOW PLAYING
Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m